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The growing application of cerium oxide nanoparticles (CeO2 NP) in several industrial 
products is likely to be associated with increased risk of inhalation and exposure. How the 
inhalation of CeO2 NP may affect cardiac structure and function has to our knowledge, not been 
examined. To examine whether inhalation of CeO2 NP affects cardiac structure and function, 
male Sprague Dawley rats underwent a single intra tracheal instillation of nanoparticles (7 
mg/kg body weight). Animals were sacrificed 1, 3, 14, and 28 days after instillation and protein 
isolates from the hearts were examined for the presence of oxidative stress, autophagy and 
apoptosis. Compared to 1 day saline controls, heart weights after instillation were decreased by 
7.8 ± 1.9%, 12.2 ± 3.4%, 10.7 ± 3.2%, and 18.6 ± 3.9% at 1, 3, 14, and 28 days, respectively 
(p<0.05). Decreases in heart weight were associated with elevations in the expression of heat 
shock proteins (HSP) and NF-kB while the expression of AMPK-α was decreased suggesting the 
induction of oxidative stress subsequent to CeO2 NP exposure. Further analysis demonstrated 
that the inhalation of the nanoparticles was also associated with elevations in the amount of 
Beclin-1 and LC3 which suggests that CeO2 NP exposure can induce autophagy in the rat heart. 
Taken together, these data suggest that the inhalation of CeO2 NP can cause increased cardiac 
oxidative stress and autophagy.  
 






There is a great deal of interest in the effects that environmental pollutants and 
particulate matter may have on the development of respiratory and cardiovascular disease. 
While air born microscopic particles are a ubiquitous result of industrialization, the  advent of 
nanotechnology and its rapid development has led to a concern related to the manufacturing 
and use of large quantities of nanoparticles (NP) (1). Many of the chemical and physical 
properties of nano-materials, such as a large surface to volume ratio and enhanced reactivity 
allow for different effects than that seen in their bulky counterparts. As such, the health effects 
of NP are attracting considerable concern from the public and governments worldwide (2).  
One particular type NP of interest is that which is composed of cerium oxide (CeO2). 
CeO2 is the most abundant member of lanthanide series of metals. CeO2 NP play a key role in 
technology and industrial applications for solar cells, fuel cells, gas sensors, oxygen pumps, and 
glass/ceramic applications (3). In addition, CeO2 NPs have also been widely used in the 
automobile industries to reduce particulate matter emissions. Given its fluorite lattice structure 
and oxygen vacancies, CeO2 NP can either give or take the oxygen atoms depending on the 
surrounding oxygen concentration (4). Recent work has also shown that the addition of cerium 
oxide to fuel reduces the nitric oxide and sulfur dioxide emissions, decreases fuel consumption 
and aids in the conversion of harmful carbon monoxide to carbon dioxide. These properties 
make cerium oxide NP an efficient catalytic converter for thermal applications such as natural 
gas combustion (4). 
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Recent studies have also suggested the CeO2 NP may have potential for biomedical 
applications. CeO2 NP have been used to suppress the inflammatory processes in the 
myocardium and in the reduction of oxidative stress (5), to help protect neurons from oxidative 
toxicity (6), for the treatment of macular degeneration and other retinal diseases by inhibiting 
reactive oxygen species levels (7) and for protecting tissues from the damaging effects of 
radiation (8).  
How CeO2 NP may cause cellular toxicity is not well understood. Most of work done to 
date has been in-vitro using cultured cells (9-11).  Based on previous studies, the toxicity of 
CeO2 NP appears to vary with size, particle shape and degree of aggregation. Because of its 
widespread application as a polishing agent in the manufacturing sector it is likely that the most 
common route of exposure to CeO2 NP will occur via inhalation.  Although recent studies have 
shown that inhaled CeO2 NP can cause lung damage and fibrosis, whether CeO2 NP can exit the 
lungs after inhalation, and if able, whether CeO2 NP are capable of damaging other organs and 
tissues is not well understood.  
In the lung, exposure to CeO2 NP is thought to be associated with increased oxidative 
stress, tissue fibrosis and evidence of increased endoplasmic reticulum stress (12). Whether 








Significance of the study 
The growing application of CeO2 NP in several industrial applications is likely to be 
associated with increased risk of exposure to these materials. A greater understanding of 
whether exposure to CeO2 NP is toxic is needed to ensure worker safety. Thus far, the potential 
effects of inhaled CeO2 NP on the heart are not well understood. This study is designed to 
specifically address this gap in our understanding.  
 
Hypothesis 
The primary objective of this study is to determine whether the inhalation of CeO2 NP is 
associated with cardiac damage. We hypothesize that CeO2 NP are capable of moving from the 
lung to the heart and that the presence of CeO2 NP in the heart will be associated with indices 
of cellular stress. To test this hypothesis, two specific aims will be pursued: 
 
Specific Aim 1: To determine if inhaled CeO2 NP can induce oxidative stress in the rat heart. 
Hypothesis: Inhaled CeO2 NP will be associated with increased cardiac oxidative stress.  
 
Specific Aim 2: To determine if inhaled CeO2 NP can induce autophagy and/or apoptosis in the 
rat heart.  









A review of the literature pertinent to the present study will be discussed in this 
chapter. The following areas will be addressed: (i.) increasing importance of nanotechnology, 
(ii.) nanoceria applications, (iii.) toxic effects of CeO2 nanoparticles, (iv.) oxidative stress 
induced by cerium oxide nanoparticles, (v.) role of heat shock proteins (HSP) in oxidative stress, 
(vi.) AMPK alpha in oxidative stress, (vii.) autophagy in response to oxidative stress, and (viii.) 
eEF-2K role in autophagy. 
 
 Increasing importance of Nanotechnology 
Nanotechnology is defined as technological applications of materials and assemblies at 
the nanometric scale (1-100 nm) (13). At the nanometer scale, the physical, chemical and 
biological properties of materials are fundamentally different from those of individual atoms, 
molecules and bulk materials (14). Nanomaterials exhibit a tremendous amount of potential for 
electronic, biomedical, pharmaceutical, cosmetic, energy, environmental, catalytic and material 
applications.  The use of nanoparticles may be of significant benefit to many aspects of our 
lives, but the possible impact(s) that these materials may have on human health is not known. 
In addition to risks from use of the nanomedicine products, there are also concerns about the 
occupational and environmental risks associated with the manufacture and disposal of nano-
drugs and nano-devices. As such, increasing our understanding of nanotoxicity is becoming a 





 Nanoceria applications 
Ceria exhibits two valance states (Ce+3 and Ce+4). CeO2 nanoparticles (CeO2NP) are 
widely used in industrial applications as well as biomedical applications. Industrial uses includes  
solar cells, fuel cells,  gas sensors, oxygen pumps,  glass/ceramic applications and the 
automobile industry (3). The addition of cerium oxide to fuel acts to reduce particulate 
emissions like nitric oxide and sulfur dioxide while it also converts harmful carbon monoxide to 
carbon dioxide (4). 
Cerium oxide nanoparticles have also been shown to act as free radical scavengers and 
may promote cell and organism longevity (15). Schubert et al., demonstrated that CeO2 
nanoparticles are able to rescue HT22 cells from oxidative stress-induced cell death (1). 
Similarly, CeO2 nanoparticles have also been shown to protect normal human breast cells from 
radiation-induced apoptotic cell death (16). In the heart, CeO2 nanoparticles have been 
demonstrated to provide protection against cardiac dysfunction and remodeling induced by 
oxidative stress and inflammation, most likely due to causing a reduction of the inflammatory 
cytokines, TNF-alpha and IL-6 (5). Nanoceria have also been shown to exhibit super oxide 
dismutase (SOD) and catalase mimetic activity in a redox-state dependent manner (17). Other 
work has demonstrated that CeO2 NP may also protect the neurons from oxidative damage (6), 
prevent macular degeneration (7) and that these particles may exhibit promise for protecting 







 Toxic effects of CeO2 nanoparticles 
The inhalation of nanoparticles is increasingly recognized as a major cause of adverse 
health effects and may be associated with increased cardiovascular disease morbidity and 
mortality (18). The results of Gómez-Aracena et al., 2006 have suggested a relationship 
between chronic cerium exposure and increased risk of acute myocardial infarction (19). In 
certain geographic regions soil containing higher levels of cerium appears to be correlated with 
higher levels of cerium in serum and cardiac tissue of individuals with endomyocardial fibrosis 
(20-22).  
Endocardial fibrosis has been shown by Kumar et al., 1995 after the administration of 
cerium chloride (1.3 mg/kg) into the tail vein of female Sprague-Dawley rats. These data were 
consistent with other work by Kumar et al., who reported that incubation of cardiac fibroblasts 
in vitro with 100 nM cerium increased RNA synthesis by 64% (Shivakumar et al., 1992).  Taken 
together, these findings suggest that low levels of cerium exposure may act at the 
transcriptional level to stimulate collagen and non-collagen protein synthesis which may 
contribute to the accumulation of collagen in endocardial fibrosis. 
 
Oxidative stress induced by cerium oxide nanoparticles 
Oxidative stress is the imbalance between production of reactive oxygen and nitrogen 
species and the ability of a system to detoxify them. Reactive oxygen species (ROS) are a group 
of free radicals having unpaired electrons (23). ROS are highly reactive and can cause oxidative 
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damage to lipids, proteins and DNA (24). It is thought that the mitochondria are a major source 
of free radical generation. To counteract these adverse effects, cells utilize antioxidant enzymes 
such as superoxide dismutase, glutathione and catalase (25). An imbalance between the 
production and degradation of ROS results in ROS accumulation and further cell damage.  
Until now, very little has been known about how nanoparticles may cause toxicity and 
the induction of oxidative stress which if unchecked can lead to apoptosis, cell cycle arrest and 
the inhibition of antioxidant enzymes. In vivo studies with aquatic species has showed that 
fullerenes can cause oxidative damage and a reduction in glutathione levels (26). Recent studies 
indicated the toxic effects of CeO2 NP are mainly through induction of oxidative stress (3, 11). In 
vitro studies using A549 cells and E. coli treated with CeO2 NP have shown elevations in cellular 
ROS, lipid peroxidation, cellular damage and reductions in cell viability (9, 27).  
It has been postulated that one of the important upstream signaling mechanisms 
responsible for regulating oxidative stress are the mitogen-activated protein kinase (MAPK) 
cascades. There are three main groups of MAPK proteins: the extracellular signal-regulating 
kinase (ERK), p38 and c-Jun N-terminal kinase (JNK) (28).  In 2008, Park et al., showed that while 
CeO2 NP exposure did not alter total MAPK expression it was associated with increased p38-
MAPK phosphorylation (3). Most of the studies involving ROS formation and MAP kinase 
signaling suggest that CeO2 NP provoke oxidative stress (3, 11). Moreover, oxidative stress 
induced by the CeO2 NP has been shown to cause 2-8 fold increases in cellular apoptosis (11). 
Although not fully understood, exposure to CeO2 nanoparticles has also been observed to cause 
elevations in caspase-3 and chromatin condensation (3).  
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Oxidative stress and increased production of ROS after nutrient deprivation and 
ischemia-reperfusion are also associated with autophagy (29). Kirkland et al., showed that loss 
of mitochondrial inner membrane lipid cardiolipin causes increased apoptosis and autophagy, 
and that this process is mediated by increases in cellular free radicals (30).  
 
 Role of heat shock proteins (HSP) in oxidative stress 
Increased production of heat shock proteins have been found to occur following cellular 
exposure to elevated temperatures, hypoxia, ischemia, heavy metal intoxication and increased 
cellular ROS levels (31). Heat shock proteins help stabilize improperly folded proteins and 
protect them from degradation (32). Hsp27 also known as HspB1 will interact with several 
cytoskeleton components like actin, microtubules and intermediate metabolites (33). The 
microfilament network is an early target of oxidative stress and is protected from degradation 
by Hsp 27 (34). Hsp27 also has a protective role following exposure to heavy metals (35). Hsp27 
also has a role in controlling apoptosis and the regulation of caspase expression (36). Other 
work has shown that Hsp27 may also play a protective role in dilated cardiomyopathy and 
ischemia-reperfusion injury (37). It is thought that HSP27 over expression increases NF-kB 
activity which may function to suppress apoptosis (38). According to Kim H, et al, inhibition of 
Hsp60 will suppress autophagy under conditions of increased oxidative stress (39). It appears 




 Role of AMPK alpha in oxidative stress  
The adenosine mono phosphate-activated protein kinase (AMPK) is an enzyme which is 
a key regulator of cellular energy balance (41). AMP-activated protein kinase is a 
serine/threonine kinase consisting of α, β and γ subunits. Among these, the α subunit consists 
of two isoforms α1 and α2. It is thought that the α subunit is catalytic in nature while the β and γ 
function to maintain the stability of the complex. Recent studies have suggested that 
suppression of AMPK activity is linked with oxidative stress (42)  and the inflammatory response 
(43). Other data has shown that inhibition of AMPK activity can ameliorate oxidative damage 
(44) and inflammation (45). Similarly, AMPK has been shown to play a protective role during 
oxidative stress while reductions of AMPK activity are associated with increases in NAD(P)H 
oxidase activity and ROS production. The AMPK activator, Metformin, has been shown to 
reduce oxidative stress in aortic endothelial cells (46). Likewise, the activation of AMPK through 
AICAR (5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside) inhibits the ROS-induced 
apoptosis in endothelial cells (47). AMPK may also have an effect on NF-kB activation as the 
activity of this pathway can be suppressed by activated AMPK which leads to decreased 
expression of NAD(P)H oxidase (42). According to Chao Liu et al., AMPK α activation promotes 
cell survival through increasing NF-kB mediated expression and suppression of apoptosis (48).  
 
Autophagy in response to oxidative stress 
Programmed cell death (PCD) has been described as an important protective 
mechanism. It is thought that there are two different forms of PCD; apoptosis and autophagy 
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(49). Autophagy is a lysosomal dependent protein degradation pathway, which involves the 
degradation of pathogens and damaged organelles allowing the reuse of nutrients under 
nutrient deprived conditions. If excessive, autophagy can be detrimental to cells and lead to cell 
death. Recent studies have shown that apoptosis and autophagy, can act simultaneously in the 
cell death processes (50).  
During autophagy, a membrane is formed around the cytoplasmic contents of interest. 
Once formed, this structure binds with lysosomes through and the components are subjected 
to enzymatic reactions within the lysosomes. Hydrolases play a key role in this enzymatic 
degradation. The resulting molecules will be released into cytoplasm for further recycling (51).  
In the last decade approximately 30 autophagy related genes (ATG genes) have been 
identified in yeast cells and 16 homologous genes have been identified in mammalian cells (52). 
Among these genes, the Beclin-1 and LC3 (microtubule associated protein light chain 3) are 
thought to play a key role in mammalian autophagy. Beclin-1 (the mammalian homolog of yeast 
Atg6 gene), is required for autophagic vesicle formation (53). Beclin 1 is identified as an 
important point of convergence between apoptosis and autophagy as it is associated with anti 
apoptotic Bcl2 like proteins (54). 
  LC3, a mammalian homolog of yeast Atg8 and is considered a reliable marker of 
autophagy as it represents the amount of autophagosomes at that particular time. Conversion 
of LC3I to LC3II is indicative of autophagic activity. Because the half-life of LC3II is short, 
autophagosomes are transient structures. LC3II levels are representative of autophagic activity 
at any one moment in time (55). During autophagy, the cytoplasmic form (LC3I) is processed 
and recruited to the autophagosomes, where LC3II is generated by site specific proteolysis near 
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the C-terminus. The hallmark of autophagic activation is thus the formation of cellular 
autophagosome punctae containing LC3II, while autophagic activity is measured biochemically 
as the amount of LC3II that accumulates in the absence or presence of lysosomal activity. It is 
thought that exposure to some nanomaterials is associated with the autophagy dysregulation in 
autophagy leading to an increase in the number of autophagosomes (56).  
 eEF-2K role in autophagy  
 eEF2 (Eukaryotic elongation factor) is required for mRNA translation elongation (57, 58). 
The phosphorylation of eEF2 at Thr-56 inactivates its inhibitory effect on mRNA translation.  
The phosphorylation of eEF2 is mediated by eEF-2K, when it is phosphorylated at Thr-366 (59). 
One of the upstream regulators of eEF-2K is transforming growth factor (TGFβ). Falguni Das and 
colleagues showed that TGF-β treatment of mesengeal cells is associated with cellular 
hypertrophy and that this process occurred via the activation of eEF2 (57). 
Both eEF2 and eEF2K are thought to play a role in the induction of autophagy. According 
to Wu et al., down regulation of eEF-2K  expression in gliobastoma cells following treatment 
with siRNA was associated with diminished autophagy and the down regulation of the 
autophagy mediator LC3 (58). Other work, using T98G gliobastoma cells that were engineered 
to over express eEF-2K has shown that elevations in eEF-2 were found to be associated with  
increased autophagy (60).  It is thought that eEF-2K plays a key role in crosstalk between 
autophagy and apoptosis as the inhibition of eEF-2K activity in tumor cells appears to suppress 





The toxic effects of CeO2 NP are thought to occur via the generation of ROS. If excessive, 
elevations in ROS can lead to changes in the degree of HSP, NF-kB, eEF-2K, AMPK, Beclin-1 and 
LC3 activity which can cause the induction of autophagy and apoptosis. How CeO2 NP may 




























The growing application of cerium oxide nanoparticles (CeO2 NP) in several industrial 
products is likely to be associated with increased risk of inhalation and exposure. How the 
inhalation of CeO2 NP may affect cardiac structure and function has to our knowledge, not been 
examined. To examine whether inhalation of CeO2 NP affects cardiac structure and function, 
male Sprague Dawley rats underwent a single intra tracheal instillation of nanoparticles (7 
mg/kg body weight). Animals were sacrificed 1, 3, 14, and 28 days after instillation and protein 
isolates from the hearts were examined for the presence of oxidative stress, autophagy and 
apoptosis. Compared to 1 day saline controls, heart weights after instillation were decreased by 
7.8 ± 1.9%, 12.2 ± 3.4%, 10.7 ± 3.2%, and 18.6 ± 3.9% at 1, 3, 14, and 28 days, respectively 
(p<0.05). Decreases in heart weight were associated with elevations in the expression of heat 
shock proteins (HSP) and NF-kB while the expression of AMPK-α was decreased suggesting the 
induction of oxidative stress subsequent to CeO2 NP exposure. Further analysis demonstrated 
that the inhalation of the nanoparticles was also associated with elevations in the amount of 
Beclin-1 and LC3 which suggests that CeO2 NP exposure can induce autophagy in the rat heart. 
Taken together, these data suggest that the inhalation of CeO2 NP can cause increased cardiac 
oxidative stress and autophagy.  
 







The ever increasing use of nanomaterials for industrial applications has led to concerns 
regarding the potential effects these materials may have on cellular life and the environment. 
When compared to bulk materials, nanoparticles exhibit an increased surface area / weight 
ratio which can leads to increased reactivity and different physico-chemical properties (2). 
Cerium dioxide nanoparticles (CeO2 NP) are widely used in the solar cells, fuel cells, gas sensors, 
and polishing industries. CeO2 NP are also used as catalysts and as fuel additives where they 
function to reduce the emission of sulfur dioxide and nitric oxide from fuel and help to covert 
carbon monoxide to carbon dioxide. Recent studies have also suggested the CeO2 NP may have 
potential for biomedical applications as antioxidant. CeO2 NP have been used to suppress the 
inflammatory processes in the myocardium and in the reduction of oxidative stress (5), to help 
protect neurons from oxidative toxicity (6), for the treatment of macular degeneration and 
other retinal diseases by inhibiting reactive oxygen species levels (7) and for protecting tissues 
from the damaging effects of radiation (8). Although very promising for in vivo application, 
whether CeO2 NP exhibit toxic effects to cells and tissues is not well understood. Thus far, most 
of work done to date has been in-vitro using cultured cells (9-11).  Although recent studies have 
shown that inhaled CeO2 NP can cause lung damage and fibrosis, whether CeO2 NP can exit the 
lungs after inhalation, and if able, whether CeO2 NP are capable of damaging other organs and 
tissues is not well understood.  
In the lung, exposure to CeO2 NP  is thought to be associated with increased oxidative 
stress, tissue fibrosis and evidence of endoplasmic reticulum stress (12). Whether CeO2 NP 
exhibit similar effects in the heart, has to our knowledge, not been investigated. Interestingly, 
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recent data has demonstrated that the inhalation of carbon nanotubes may be associated with 
the deposition of nanotubes elsewhere in the body (63). On the basis of these data, we 
hypothesized that CeO2 NP inhalation could lead to the translocation of CeO2 NP from the heart 
to the lung. In addition, we also hypothesized that the presence of CeO2 NP in the heart would 
be associated with evidence of oxidative stress. Taken together, our data suggest that the 
inhalation of CeO2 NP is associated with increased oxidative stress and autophagy in hearts of 




Materials and Methods 
Particle characterization  
CeO2 nanoparticles, 10% weight in water (average diameter at ~20 nm), were obtained 
from Sigma-Aldrich (St Louis, MO).  For installation normal saline was used as vehicle. Diluted 
particle suspensions were filtered, sputter coated, and examined with a Hitachi Model S-4800 
Field Emission scanning electron microscope (Schaumburg, IL, USA) at 5 and 20 kV or placed on 
a formvar-coated copper grid to dry and imaged with a JEOL 1220 transmission electron 
microscope (Tokyo, Japan).  
 
Animals 
All procedures were performed in accordance with the Marshall University Institutional 
Animal Care and Use Committee (IACUC) guidelines, using the criteria outlined by the 
Assessment and Accreditation of Laboratory Animal Care (AAALAC). 5 weeks old 150-174 g 
weighing Specific pathogen-free male Sprague-Dawley (Hla: SD-CVF) rats were purchased from 
Hilltop Lab Animals, Inc. (Scottdale, PA, USA). Rats were housed two per cage in an AAALAC 
approved vivarium with a 12-h light–dark cycle, temperature maintained at 22 ± 2 °C, and fed 
ad libitum. All animals were allowed to acclimatize for 2 weeks before initiation of any 
treatment or procedures. All animals were examined for precipitous weight loss, failure to 
thrive or unexpected gait. Periodic weight measurements were taken throughout the duration 






Beclin-1 (#3738), LC3B (#2775), Phospho AMPK-α Thr 172(#2535), AMPK-α ( #2532), Bax ( 
#2772), Bcl-2( # 2870), Phospho eEF-2k Ser 366( #3691), eEF-2k(#3692), Hsp60(D307)(#4870) 
Mouse IgG, and Rabbit IgG antibodies were purchased from cell signaling technology(Beverly, 
MA). NF-kB p50 (E-10)(sc-8414), Hsp27 (M-20)(sc-1049), HeLa whole cell lysate (sc-2200) and 
L6+ IGF lysate(sc-24727) were purchased from Santa Cruz Biotechnology(Santa Cruz, CA). 
Enhance chemiluminescence (ECL) western blotting detection reagent was purchased from 
Amersham Biosciences (Piscataway, NJ). Restore western blot stripping buffer was obtained 
from Pierce (Rockford, IL). Dihydroethidium (5mM standard solution in DMSO) was purchased 
from molecular probes (Invitrogen, OR). TUNEL assay kit was purchased from Roche diagnostics 
corporation (Mannheim, Germany). All other chemicals were purchased from Sigma Aldrich 
(St.Louis,MO) or Fisher Scientific (Hanover, IL). 
 
Rationale for Dose at the rate of 7mg/kg B.wt 
The dose i.e 7mg/kg B.wt was determined by an estimation of the amount of CeO2 that can be 
inhaled from diesel exhaust over an 8 hr period is 0.09 μg/kg (HEI, 2001). The total lung burden 
after 40 years of occupational exposure can be estimated as the following as 0.09 ug/kg/d X 5 
d/week X 52 week/year X 40 years = 936 μg/kg and the safety factor conversion from humans 
to rodents is 10. So it is reasonable to examine the systemic toxicological effects of CeO2 
nanoparticles exposure from 1.0 mg/kg to 7.0mg/kg. Previous studies show that it took 28 days 
to observe histological alterations in the lungs (64). So we investigated the effects of CeO2 NP 
on the heart for 28 days. 
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Instillation of CeO2 nanoparticles 
After acclimatization, animals were divided randomly into 8 groups (n=6 per group). 
Each group of the animals were anesthetized with sodium methohexital (35 mg/kg, i.p.) and 
placed on an inclined restraint board before instillation with 0.3 ml of saline suspension of CeO2 
nanoparticles at a dose rate of 7mg/kg B.wt. All animals were humanely treated and were 
monitored for any potential suffering. Rats were euthanized and collected the tissues at 1, 3, 
14, and 28 days post exposure of CeO2 nanoparticles and control groups with normal saline 
according to the Guidelines for the Care and Use of Laboratory Animals. 
 
Tissue collection 
Rats were anesthetized with a ketamine–xylazine (4:1) cocktail (50 mg/kg, I/P) and 
supplemented as necessary for reflexive response before tissue collections. The heart was 
removed and placed in Krebs–Ringer bicarbonate buffer (KRB) containing; 118 mM NaCl, 4.7 
mM KCl, 2.5 mM CaCl2, 1.2 mM KH2PO4, 1.2 mM MgSO4, 24.2 mM NaHCO3, and 10 mM α-D-
glucose (pH 7.4) equilibrated with 5%CO2/95%O2 and maintained at 37
0 C. Blood and other 
tissue materials are removed from the Isolated hearts, then weighed, and immediately snap 
frozen in liquid nitrogen.  
 
TUNEL staining 
Heart tissues (control, day 1, 3 and 14 post exposure) were sectioned (8 µm) using an 
IEC Microtome cryostat and collected on poly-lysine coated slides. DNA fragmentation was 
determined by TdT-mediated dUTP nick end labeling (TUNEL) as outlined by the manufacturer 
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(In Situ Cell Death Detection Kit, Roche Diagnostics, Mannheim, Germany). Briefly, sections 
were fixed with 4% paraformaldehyde, washed with PBS (pH 7.4), and then permeabilized with 
0.1% sodium citrate and 0.1% Triton-X.  Nuclei were counter stained using DAPI (VECTASHIELD 
Hard Set Mounting Medium, Vector Laboratories, Burlingame, CA). Heart cross sections were 
visualized by epifluorescence using an Olympus fluorescence microscope (Melville, NY) fitted 
with 20X and 40X objectives and images were recorded digitally using a CCD camera (Olympus, 
Melville, NY). The number of TUNEL positive nuclei was counted in three randomly selected 
regions in each slide. Three different animals were counted from each group. Tissue sections 
treated with DNase I to induce DNA fragmentation were used as a positive control. 
 
DHE staining 
Hydroethidine (HE) staining was used to detect superoxide radical generation. 
Hydroethidine is cell permeable and in the presence of free oxygen radicals becomes oxidized 
to ethidium bromide which intercalates with DNA (65). Heart tissue sections (8 µm) were 
incubated with 5 µM dihydroethidium stain (Invitrogen, OR) at 370 C for 30 min. After thorough 
washing with PBS (pH 7.4) mounting with DAPI (VECTASHIELD Hard Set Mounting Medium, 
Vector Laboratories, Burlingame, CA) sections were visualized for epifluorescence using an 
Olympus fluorescence microscope (Melville, NY). Images were recorded digitally using a CCD 
camera (Olympus, Melville, NY). Images from four randomly selected regions from each slide 
were collected for observation. Data was collected from at least three animals at each time 




Immunoblotting analysis  
Portions of individual heart tissues (100-150mg) were homogenized in buffer (T-PER, 8 
mL/g tissue; Pierce, Rockford, IL) containing protease (P8340, Sigma-Aldrich, Inc., St. Louis, MO, 
USA) and phosphatase inhibitors (P5726, Sigma-Aldrich, Inc., St. Louis, MO). Tissue 
homogenates were sonicated (3 x 30 sec cycles at 50 W) and the supernatant collected by 
centrifuging (12,000g x 5 min at 4 °C). Protein concentrations were determined in triplicate 
using the 660 nm assay method (Thermo Scientific, Rockford, IL). Equal concentrations of the 
protein samples were prepared from each of the individual samples by adding equal quantities 
of sample buffer and adjusting the protein concentration with the TPER lysis buffer. Samples 
were boiled in a Laemmli sample buffer (Sigma-Aldrich, Inc., St. Louis, MO) for 5 min. Forty 
micrograms of total protein for each sample was separated on a 10% PAGEr Gold Precast gel 
(Lonza, Rockland, ME) and then transferred to nitrocellulose membranes (Amersham, NJ). Gels 
were stained with a RAPID Stain protein stain reagent (G-Biosciences, St. Louis, MO, USA) to 
verify transfer efficiency. Membranes were stained with Ponceau S and the amount of protein 
was quantified by densitometry to confirm successful transfer of proteins and equal loading of 
lanes. Membranes were blocked with 5% milk in Tris Buffered Saline (TBS) containing 0.05% 
Tween-20 (TBST) for 1 h and then incubated with primary antibody overnight at 4C. After 
washing with 1%TBST, the membranes were incubated with the corresponding secondary 
antibodies conjugating with horseradish peroxidase (HRP) (anti-rabbit (#7074) or anti-mouse 
(#7076), Cell Signaling Technology, Danvers, MA) for 1 h at room temperature. Protein bands 
were visualized following reaction with ECL reagent (Amersham ECL Western Blotting reagent 
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NJ). Target protein levels were quantified by AlphaView image analysis software (Alpha 
Innotech, San Leandro, CA).  
 
Data Analysis 
Results are presented as mean ± SEM. Data were analyzed using the Sigma Plot 11.0 
statistical program. One-way analysis of variance was performed for overall comparisons, while 
the Student–Newman–Keuls post hoc test used to determine differences between groups. 




CeO2 NP inhalation decreases heart weight 
Compared to control animals, CeO2 NP exposure did not affect feed intake and weight 
gain (Table 2). Compared to age matched control animals, heart weights were 7.8 ± 1.9%, 12.2 
± 3.4%, 10.7 ± 3.2%, and 18.6 ± 3.9% less at 1, 3, 14 and 28 days, respectively (P<0.05) (Table 1). 
 
CeO2 NP inhalation increases superoxide levels but not TUNEL reactivity 
The quantification of O2
- was determined semi-quantitatively by assessing the oxidation 
of hydroethidine to ethidium bromide. Compared to control animals, the amount of ethidium 
fluorescence was 34.4 ± 12.3%, 78.6 ± 6.4%, and 72.1 ± 8.6% higher at 1, 3, and 14 days post 
exposure, respectively (P<0.05)(Figure 1). Compared to control animals, CeO2 inhalation did not 
increase the number of TUNEL reactive cells at any time (Data not shown).  
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CeO2 NP inhalation increases HSP27 and HSP60 expression   
The abundance of HSP27 and HSP60 were determined from protein isolates obtained 
from each of the different groups. Compared to control animals, the amount of HSP27 was 27.1 
± 3.8%, 33.7 ± 4.6%, 36.7 ± 5.1%, and 17.4 ± 6.2% higher at 1, 3, 14 and 28 days after CeO2 
instillation, respectively (P<0.05) (Figure 2). Similarly, HSP60 expression was 9.9 ± 5.8%, 41.4 ± 
2.8%, 58.2 ± 7.0%, and 48.7 ± 4.8% higher after 1, 3, 14, and 28 days, respectively (P<0.05) 
(Figure 3). 
 
CeO2 NP inhalation alters AMPK-α phosphorylation and NF-kB expression  
Compared to control animals, CeO2 NP inhalation decreased the amount of 
phosphorylated AMPK-α by 23.5 ± 1.8% and 27.2 ± 1.2% at 1 and 3 days post instillation 
(P<0.05). Conversely, CeO2 NP inhalation, appeared to increase AMPK-α phosphorylation by 
15.5 ± 5.1% and 20.6 ± 5.7% at days 14 and 28 post exposure (P<0.05) (Figure 5). Compared to 
that observed in the control animals, NF-kB p50 protein levels in CeO2 exposed animals were 
42.8 ± 9.5% and 25.4 ± 7.5% higher at days 14 and 28 day, respectively (P<0.05) (Figure 4). 
 
CeO2 NP inhalation increases the ratio of Bax/Bcl-2 protein one day after exposure  
Compared to control animals, the ratio of Bax / Bcl-2 protein was 42.4 ± 6.9% higher in 
CeO2 exposed animals at day 1 (P<0.05). Conversely, the ratio of Bax / Bcl-2 was 26.4 ± 3.3% 





CeO2 NP inhalation appears to be associated with increased cardiac autophagy 
Compared to control animals, the expression of Beclin-1 was 21.0 ± 2.2%, 18.9 ± 1.9%, 
and 13.9 ± 2.3% higher 1, 3 and 14 days post exposure, respectively (P<0.05) (Figure 7). 
Similarly, LC3-II protein content was 26.1 ± 1.9 and 57.4 ± 11.7 higher 3 and 28 days post 
exposure (P<0.05) (Figure 8).  Compared to control animals, with CeO2 inhalation, the 
phosphorylation of eEF-2K was 18.1 ± 3.5%, 19.9 ± 5.2%, and 19.5 ± 4.5% higher at days 1, 3, 
and 14 day post exposure (P<0.05) (Figure 9). 
 
Discussion 
CeO2 NP are widely used in a number of industrial applications and in the fuel cell, solar 
cell and polishing industries. It is thought that CeO2 NP may also exhibit potential medical use 
given their ability to act as a free radical scavenger. Recent in vitro studies have suggested that 
CeO2 NP may also have toxic effects given their proclivity to increase the generation of reactive 
oxygen species and decease intracellular glutathione levels in cells at higher concentrations (3). 
Whether CeO2 NP are toxic to cardiac cells in vivo, has to our knowledge, not been investigated. 
The primary finding of this study is that CeO2 NP inhalation appears to be associated with 
evidence of increased oxidative stress in the Sprague Dawley rat heart (Figure 1). This increase 
in oxidative stress was found to be associated with alterations in the amount of autophagic 
(Beclin-1, LC3-II), transcriptional (NF-kB) and heat shock (HSP27, HSP 60) protein expression 
(Figures 2- 9).  
How nanoparticles may cause cellular toxicity is not well understood. Recent data has 
suggested that nanoparticles exposure is oftentimes associated with increases in cellular 
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reactive oxygen species (3, 9, 11, 26, 27). We observed similar findings in the present study 
(Figure 1). On the basis of previous reports showing that HSP expression are regulated, at least 
in part, by oxidative stress levels (31, 34), we next examined if cerium oxide inhalation was 
associated with increases in the amount of cardiac heat shock protein HSP27 and HSP60. It is 
thought that HSP function in various capacities to minimize cellular damage (32). As an 
example, the Hsp27 has been shown to exhibit anti-apoptotic activity (36) while other work has 
also shown that Hsp27 over expression can increase the activity of NF-kB (38). Compared to 
control animals, our data suggest that CeO2 NP inhalation is associated with elevations in both 
Hsp27 and Hsp60 levels (Figure 2 and 3). Like that observed for the HSPs, the expression of NF-
kB was also elevated after inhalation CeO2 NP (Figure 4). Similar to the HSPs, elevations in NF-kB 
have also been shown to induced by increases in cellular ROS (66) where they, like the HSPs 
may function to protect the cell from apoptosis (37). Whether these elevations in HSP and NF-
kB protein expression are a direct result of the increased oxidative stress associated with the 
inhalation of CeO2 NP is currently unclear. 
Interestingly, we found that the amount of phosphorylated AMPK was lower in the 
animals that were sacrificed after 1- and 3 days of CeO2 inhalation and higher, compared to 
control, in animals that were sacrificed after 14- and 28 days of CeO2 inhalation (Figure 5). It is 
thought that the AMPK functions as an energy sensor and that diminished AMPK 
phosphorylation can be caused by increases in oxidative stress or by cellular inflammation (42, 
43). Some studies indicated increased AMPK phosphorylation will cause increased expression of 
NF-kB protein and further suppression of apoptosis (48). Our results indicated increased 
26 
 
expression of AMPK in 14 and 28 days post exposure. The other pathways influenced the 
increased expression of NF-kB protein is unclear and further investigation is needed. 
Two downstream outcomes of increased oxidative stress are the induction of 
programmed cell death and autophagy. It is thought that the transition to cellular apoptosis is 
controlled, at least in part, by the ratio of the pro-apoptotic Bax protein and the anti-apoptotic 
Bcl-2 proteins (67). Herein, we found an elevation in the ratio of Bax / Bcl-2 one day after CeO2 
exposure suggesting that cerium oxide inhalation may be associated with increases in cardiac 
apoptosis (Figure 6). Whether this latter possibility actually occurs will require further 
investigation.  
Similar to that seen with apoptosis, previous work has suggested that autophagy 
proteins may play a protective role in maintaining overall tissue function (51). To examine if 
cerium oxide inhalation is associated with cardiac authophagy we next examined the tissue 
levels of the autophagy regulators beclin-1 and LC3-II levels (53, 54). Our data demonstrated 
increases in amount of beclin-1 at 1, 3, and 14 days post exposure (Figure 7). Consistent with 
these data, we also found increases in LC3-II protein levels at days 3 and 28 day (Figure 8). 
Similar to what we observed for beclin-1, and consistent with the induction of autophagy (60), 
eEF-2K protein levels were found to be elevated at 1, 3 and 14 days post exposure (Figure 9). 
Elevated expression of these three autophagy related proteins clearly indicated there is 
increased autophagy in the absence of apoptosis which suggest that this process is a pro-
survival mechanism rather than one associated with cell death.  
Taken together, our data suggest that intra tracheal instillation of CeO2 NP in male 
Sprague Dawley rats is associated with increased oxidative stress in the heart, elevations in the 
27 
 
amount of Hsp27, Hsp60, and NF-kB protein expression. These alterations were, in turn, also 
associated with evidence of cardiac autophagy (Figure 10). Given these findings, future work to 






TABLES AND FIGURES 
 
Table 1. Effect of CeO2 inhalation on rat body and heart weight. 
 
                                    Groups                      
 
                                  Control            1day                3 day              14 day                    28 day  
                                                         CeO2 NP        CeO2 NP          CeO2 NP                CeO2 NP 
 
 
Body weight, g      319.6±6.4 319.6±6.2   331.6±9.8       332.3±8.6             411.3±11.9 
 
Heart weight, g       1.1±0.03 1.2±0.11     1.0±0.02        1.1±0.03              1.3±0.04 
 
Heart wt / B.wt           3.64±0.02        3.36±0.02*   3.2±0.03*              3.25±0.03*                2.96±0.04* 
 












Table 2. Effect of CeO2 inhalation on rat feed intake and body weight gain per week 
 
 
                                    Groups                      
 
                                  14 day              14 day                  28 day                           28 day                      
                                  Control            CeO2 NP         Control      CeO2 NP   
                
 
 
Feed intake (g)      179.1±10.0 196.1±15.5              192.3±4.5                          189.2±4.1 
 















Figure 1. CeO2 NP instillation increases cardiac superoxide levels.  
Cardiac ROS determined by intensity of fluorescent ethidium bromide – stained nuclei. Results 
are expressed as a means ± SEM. * significantly different from 1 day control (p<0.05). n=4 












Figure 2. Expression of Hsp27 is altered with CeO2 NP instillation. 
Protein samples from 1 day control, 1 day, 3 day, 14 day, and 28 day CeO2 NP were analyzed by 














Figure 3. Expression of Hsp60 is altered with CeO2 NP instillation.  
Protein samples from 1 day control, 1 day, 3 day, 14 day, and 28 day CeO2 NP were analyzed by 
















Figure 4. Expression of NF-kB p50 is altered with CeO2 NP instillation. 
Protein samples from 1 day control, 1 day, 3 day, 14 day, and 28 day CeO2 NP were analyzed by 
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                                                                      Figure 5 
 
 Figure 5. Phosphorylation of AMPK α is altered with CeO2 NP instillation. 
Protein samples from 1 day control, 1 day, 3 day, 14 day, and 28 day CeO2 NP were analyzed by 
immunoblotting. Results are expressed as a means ± SEM. * significantly different from 1 day 
control (p<0.05). 









  Figure 6. Expression of Bax/Bcl-2 is altered with CeO2 NP instillation.  
Protein samples from 1 day control, 1 day, 3 day, 14 day, and 28 day CeO2 NP were analyzed by 











Figure 7. Expression of Beclin-1 is altered with CeO2 NP instillation.  
Protein samples from 1 day control, 1 day, 3 day, 14 day, and 28 day CeO2 NP were analyzed by 



















Figure 8. Conversion of LC3 is altered with CeO2 NP instillation.  
Protein samples from 1 day control, 1 day, 3 day, 14 day, and 28 day CeO2 NP were analyzed by 














                                                  




Figure 9. Phosphorylation of eEF-2K is altered with CeO2 NP instillation. 
Protein samples from 1 day control, 1 day, 3 day, 14 day, and 28 day CeO2 NP were analyzed by     
















Figure 10. Effects of CeO2 NP inhalation on the Sprague Dawley rat heart. 
 
       









Conclusions      
Cerium oxide is widely used in several industrial applications and may also exhibit potential 
use for the treatment of various biomedical conditions. Here we examine the potential 
toxicological effects of inhaled CeO2 NP on the heart. Our data suggest that the inhalation of 
CeO2 NP is associated with increased cardiac oxidative stress and evidence of cardiac 
autophagy.  
Specifically, our data suggest the following:  
1. Inhalation of CeO2 NPs is associated with diminished heart mass. 
2. Inhalation of CeO2 NPs is associated with evidence of increased cardiac superoxide 
levels. 
3. Inhalation of CeO2 NPs is associated with increased expression of heat shock proteins in 
the heart.  
4. Inhalation of CeO2 NPs is associated with evidence of increased cardiac autophagy in the 
absence of cardiac apoptosis.  
Future directions 
Our results suggest that the inhalation of CeO2 NP poses a potential toxicity risk to the 
heart. The time course of this study was relatively short in that it only last four weeks. As such, 
it is not clear if the effects we observed at one month post exposure represent long term 
changes or not. On the basis of these data, it may be useful for future studies to investigate the 
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long term effects of inhalation exposure to CeO2 NP. In addition, it is not clear if CeO2 NP 
accumulate over time in the heart. This lack in our understanding could also be addressed. 
Similarly it is unclear if the changes we see at the biochemical level are associated with changes 
in cardiac structure and function. To address this, future studies could also be done using 
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